Sleep Medicine
Volume 10, Issue 1 , Pages 87-94 , January 2009

Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome

Received 4 July 2007 ,Revised 8 October 2007 ,Accepted 28 October 2007.

References 

  1. Douglas NJ, Polo O. Pathogenesis of sleep apnoea/hypopnea syndrome. Lancet. 1994;344:653–655
  2. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause or consequence?. Lancet. 1994;344:721–724
  3. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162:566–570
  4. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002;165:934–939
  5. Barcello A, Mirrales C, Barbe F, Villa M, Pons S, Agusti AGN. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J. 2000;16:644–647
  6. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004;27:123–128
  7. Saarelainen S, Lehtimaki T, Jaak-kola O, Poussa T, Nikkila M, Solakivi T, et al. Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea. Clin Chem Lab Med. 1999;37:517–520
  8. Carpagnano CE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest. 2002;122:1162–1167
  9. Carpagnano CE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003;124:1386–1392
  10. Yamamuchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, et al. Oxidative stress in obstructive sleep apnea. Chest. 2005;127:1674–1679
  11. Christou K, Markoulis N, Moulas A, Pastaka C, Gourgoulianis KI. Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath. 2003;7:105–107
  12. Christou K, Moulas A, Pastaka C, Gourgoulianis KI. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med. 2003;4:225–228
  13. Rechtschaffen A, Kales A. A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute; 1968;
  14. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667–89.
  15. Atlas task force of the American Sleep Disorders Association. EEG Arousals: scoring rules and examples. Sleep 1992;15:174–184.
  16. Cesarone MR, Belcaro G, Carratelli M, Cornelli U, De Sanctis MT, Incandela L, et al. a simple test to monitor oxidative stress. Int Angiol. 1999;20:127–130
  17. Papageorgiou E, Kostikas K, Kiropoulos T, Karetsi E, Mpatavanis G, Gourgoulianis KI. Increased oxidative stress in exudative pleural effusions: a new marker for the differentiation between exudates and transudates?. Chest. 2005;128:3291–3297
  18. Daniil ZD, Papageorgiou E, Koutsokera A, Kostikas K, Kiropoulos T, Papaioannou AI, et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 2006 [epub ahead of print].
  19. Suzuki YJ, Jain V, Park A, Day RM. Oxidative stress and oxidant signalling in obstructive sleep apnea and associated cardiovascular diseases. Free Rad Biol Med. 2006;40:1683–1692
  20. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med. 1998;25:404–433
  21. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ Res. 2000;86:494–501
  22. Barcelo A, Elorza MA, Barbe F, Santos C, Mayoralas LR, Agusti AG. Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms. Eur Respir J. 2001;17:728–732
  23. Marshall C, Mamary AJ, Verhoeven AJ, Marshall BE. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am J Resp Cell Mol Biol. 1996;15:633–644
  24. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–1904
  25. Ramanathan L, Gulyani S, Nienhuis R, Siegel JM. Sleep deprivation decreases superoxide dismutase activity in rat hippocampus and brainstem. Neuroreport. 2002;13:1387–1390
  26. Wali SO, BaHammam ASO, Massaeli H, Pierce GN, Iliskovic N, Signal PK, et al. Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep. 1998;21:290–296
  27. Svatikova A, Wolk R, Lerman L, Juncos L, Greene E, McConnell J, et al. Oxidative stress in obstructive sleep apnoea. Eur Heart J. 2005;26:2435–2439
  28. Lavie L. Obstructive sleep apnoea syndrome – an oxidative stress disorder. Sleep Med Rev. 2003;7:35–51
  29. Barcelo A, Barbe F. Oxidative stress and sleep-hypopnea syndrome. Arch Bronconeumol. 2005;41:393–399
  30. Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, et al. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm. 2004;111:683–689
  31. Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G, et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm. 2006;113:239–254
  32. Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, et al. Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respir J. 2006;28:378–385
  33. Hernadez C, abreu J, Abreu P, Colino R, Jimenez A. Effects of nasal positive airway pressure treatment on oxidative stress in patients with sleep apnea–hypopnea syndrome. Arch Broconeumol. 2006;42:125–129
  34. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, et al. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003;88:4673–4676
  35. Harman SM, Liang L, Tsitouras PD, Gucciardo F, Heward CB, Reaven PD, et al. Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography–mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med. 2003;35:1301–1309
  36. Martin GM, Austad SN, Johnson TE. Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat Genet. 1996;13:25–34
  37. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916–1923
  38. Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 1997;95:2617–2622
  39. Hirai N, Kawano H, Yasue H, Shimomura H, Miyamoto S, Soejima H, et al. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation. 2003;108:1446–1450
  40. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med. 2007;3:467–472
  41. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–741

PII: S1389-9457(07)00367-X

doi: 10.1016/j.sleep.2007.10.011

Sleep Medicine
Volume 10, Issue 1 , Pages 87-94 , January 2009